35,588 Shares in Perrigo Company plc $PRGO Purchased by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp acquired a new stake in shares of Perrigo Company plc (NYSE:PRGO) in the third quarter, HoldingsChannel reports. The fund acquired 35,588 shares of the company’s stock, valued at approximately $793,000.

Other institutional investors also recently made changes to their positions in the company. State Street Corp grew its position in shares of Perrigo by 9.5% during the second quarter. State Street Corp now owns 7,340,323 shares of the company’s stock worth $196,134,000 after buying an additional 637,678 shares in the last quarter. Ion Asset Management Ltd. boosted its stake in Perrigo by 34.7% during the 2nd quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company’s stock valued at $102,007,000 after acquiring an additional 983,727 shares during the last quarter. Perpetual Ltd grew its holdings in Perrigo by 64.2% during the 3rd quarter. Perpetual Ltd now owns 3,149,878 shares of the company’s stock worth $70,148,000 after acquiring an additional 1,231,400 shares in the last quarter. BW Gestao de Investimentos Ltda. increased its position in shares of Perrigo by 13.2% in the 2nd quarter. BW Gestao de Investimentos Ltda. now owns 1,469,524 shares of the company’s stock worth $39,266,000 after purchasing an additional 171,080 shares during the last quarter. Finally, Edmond DE Rothschild Holding S.A. raised its stake in shares of Perrigo by 9.9% in the 2nd quarter. Edmond DE Rothschild Holding S.A. now owns 1,441,428 shares of the company’s stock valued at $38,515,000 after purchasing an additional 129,908 shares in the last quarter. 95.91% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on PRGO shares. Zacks Research downgraded Perrigo from a “hold” rating to a “strong sell” rating in a research note on Friday, November 7th. Canaccord Genuity Group decreased their target price on Perrigo from $40.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday, November 6th. Argus upgraded Perrigo to a “hold” rating in a report on Wednesday, January 14th. Wall Street Zen cut Perrigo from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Finally, Jefferies Financial Group lowered their target price on shares of Perrigo from $27.00 to $23.00 and set a “hold” rating for the company in a research note on Monday, October 27th. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Perrigo presently has a consensus rating of “Reduce” and an average target price of $20.33.

Perrigo Stock Up 3.4%

Perrigo stock opened at $14.21 on Friday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.44 and a current ratio of 2.51. Perrigo Company plc has a one year low of $12.17 and a one year high of $30.93. The company has a 50-day simple moving average of $13.96 and a 200-day simple moving average of $19.10. The firm has a market capitalization of $1.96 billion, a P/E ratio of -37.39, a P/E/G ratio of 1.24 and a beta of 0.40.

Perrigo (NYSE:PRGO) last posted its earnings results on Wednesday, November 5th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.75 by $0.05. Perrigo had a negative net margin of 1.21% and a positive return on equity of 9.16%. The firm had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same period in the previous year, the business posted $0.81 EPS. Perrigo’s revenue was down 4.1% on a year-over-year basis. Perrigo has set its FY 2025 guidance at 2.700-2.80 EPS. As a group, equities analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current year.

Insider Transactions at Perrigo

In other Perrigo news, Director Geoffrey M. Parker purchased 7,500 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was bought at an average price of $14.18 per share, with a total value of $106,350.00. Following the completion of the purchase, the director owned 17,375 shares in the company, valued at $246,377.50. This trade represents a 75.95% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.70% of the company’s stock.

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.